Irritable Bowel Syndrome Clinical Trials Irritable Bowel Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

FDA Eliminates REMS for Lotronex (alosetron hydrochloride)
September 8, 2023 --  Lotronex (alosetron hydrochloride) and approved generics are FDA approved for the treatment of irritable bowel syndrome in women whose predominant bowel symptom is diarrhea. Although safety risks for Lotronex (alosetron... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 8, 2023 Category: Pharmaceuticals Source Type: clinical trials

Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Intervention:   Diagnostic Test: colonoscopy Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Jinhua Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials